Delivery Order SPE2DB20D3103-SPE2DB22FN3K5

Award Date 4/12/22
Potential Completion Date 4/13/22
Potential Value $8.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $35,104.95 for the provision of the pharmaceutical product Pred Forte 1% eye drops. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
This federal contract award, valued at $2,616.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of PRED FORTE 1% EYE DROPS 5ML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as the primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $29,470.41 for the supply of PRED FORTE 1% eye drops. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating the contract was competitively awarded. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,092.32 firm-fixed-price delivery order covers the supply of Pred Forte 1% eye drops. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $45,065.04 for the supply of the pharmaceutical product PRED FORTE 1% EYE DROPS 10ML. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pred Forte 1% eye drops, a prescription pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,763.90 and an ultimate completion date of March 18, 2022. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pred Forte 1% eye drops, a pharmaceutical product, with a ceiling value of $6,797.24 and a performance period ending on December 6, 2023. The contract is a Firm Fixed Price Delivery Order, which is a commonly used contracting mechanism for the procurement of medical supplies and pharmaceuticals by the DLA to support...
This federal contract award, valued at $6,256.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4554557692 PRED FORTE 1% EYE DROPS 5ML, a pharmaceutical product. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,287.01, is for the delivery of Pred Forte 1% eye drops. The contract has a firm fixed price and is set to be completed by May 25, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,854.41, is for the delivery of Pred Forte 1% eye drops. The contract type is a delivery order with a firm fixed price. This order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (parent company of Amerisourcebergen Drug Corp) and the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FN3K5
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $8,106.36 for the supply of the pharmaceutical product Pred Forte 1% eye drops. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 13, 2022.

The contract is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract award did not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:32 PM